For the Inventor, By the Inventor

Enter assignee name

Seattle, WA, United States of America

Genetic Systems Corporation

Calculating rank

USPTO Granted Patents = 31

Forward Citations = 706

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Robert C Nowinski (8 out of 8 patents)

Allan Sachs Hoffman (7 out of 48 patents)

Wesley Loren Cosand (6 out of 11 patents)

4. Nobuo Monji (5 out of 7 patents)

5. Carol-Ann Cole (3 out of 4 patents)

6. John H Priest (3 out of 19 patents)

7. Raymond L Houghton (3 out of 4 patents)

8. Susan M Watanabe (3 out of 5 patents)

9. Susan McArdle (3 out of 3 patents)

10. Mark E Lostrom (3 out of 4 patents)

11. Mae Joanne Rosok (2 out of 9 patents)

12. Gerald L Klein (2 out of 11 patents)

13. Pamela J Ward (2 out of 2 patents)

14. Edward A Clark (1 out of 16 patents)

15. David Klatzmann (1 out of 34 patents)

Core Competencies:

Synthetic Antigen

Immunoassay

Monoclonal Antibody

Polymerization

Pseudomonas Aeruginosa

Antibody Assays

Retrovirus

HLA Determinant

Immunofluorescence

Viruses

Peptides

Lymphocyte Monitoring

31 patents: Sort by Forward Citations

1. 6130314 - Synthetic antigen for the detection of AIDS-related disease (2000-10-10),

2. 5716829 - Diagnostic test for Pseudomonas aeruginosa infections (1998-02-10),

3. 5514542 - Methods for propagating retrovirus for use in antibody assays (1996-05-07),

4. 5459043 - Hybridoma CT43 producing a monoclonal antibody to a novel mucin epitope (1995-10-17),

5. 5439792 - Cysteine thiol-protected peptides for use in immunoassays (1995-08-08),

6. 5369010 - Monoclonal antibody to polymorphic HLA determinant -B27 (1994-11-29),

7. 5206178 - Membrane affinity concentration immunoassay (1993-04-27),

8. 5206136 - Rapid membrane affinity concentration assays (1993-04-27),

9. 5196308 - Methods for identifying the DQw3.2 allele associated with increased risk (1993-03-23),

10. 5175098 - Expression and diagnostic use of gag encoded peptides which are (1992-12-29),

11. 5175097 - Expression and diagnostic use of GAG-1 encoded peptides which are (1992-12-29),

12. 5104790 - Monoclonal antibodies to specific antigenic regions of the human (1992-04-14),

13. 5087557 - Human monoclonal antibody to lymphadenopathy-associated virus (1992-02-11),

14. 5075211 - Synthetic antigen for the detection of AIDS-related disease (1991-12-24),

15. 5068178 - Method of enhancing direct immunofluorescence staining of cells (1991-11-26),

Company Overview

Genetic Systems Corporation, based in Seattle, WA, specializes in the development and manufacturing of advanced genetic analysis technologies. The company focuses on innovative solutions in the fields of molecular diagnostics and biotechnology, aiming to enhance genetic research and healthcare applications. With a commitment to scientific advancement, Genetic Systems Corporation plays a significant role in the evolution of genetic testing and personalized medicine, contributing to improved patient outcomes and research capabilities.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

31 Patents

#73 in Seattle, WA

#234 in Washington

#10,936 in US

#21,284 in the World

Seattle, WA, United States of America

Genetic Systems Corporation

Forward Citations = 706

40 inventors:

Robert C Nowinski (8 out of 8 patents)

Allan Sachs Hoffman (7 out of 48 patents)

Wesley Loren Cosand (6 out of 11 patents)

4. Nobuo Monji (5 out of 7 patents)

5. Carol-Ann Cole (3 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genetic Systems Corporation. Retrieved from https://idiyas.com/company/genetic-systems

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…